CA
VCYT icon

Continuum Advisory’s Veracyte VCYT Stock Holding History

Continuum Advisory’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.35K Buy
+57
New +$2.39K ﹤0.01% 1590
2025
Q2 		– Sell
-58
Closed -$1.72K – 1526
2025
Q1 		$1.72K Sell
58
-7
-11% -$267 ﹤0.01% 1389
2024
Q4 		$2.57K Buy
65
+12
+23% +$454 ﹤0.01% 1338
2024
Q3 		$1.96K Buy
53
+37
+231% +$1.04K ﹤0.01% 1432
2024
Q2 		$347 Hold
16
– – ﹤0.01% 1649
2024
Q1 		$330 Buy
+16
New +$390 ﹤0.01% 1650

Other funds holding VCYT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Continuum Advisory's VCYT Position: Q2 2026 in Review

Continuum Advisory opened a new position in Veracyte (VCYT) in Q2 2026: 57 shares worth $3.35K. The stake represents ﹤0.01% of the portfolio and ranks #1590 among its holdings. This is a return to the name: Continuum Advisory previously reported a position in VCYT as recently as Q1 2025.

Continuum Advisory first reported a position in VCYT in Q1 2024 and has held it in 6 quarters since. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Continuum Advisory held 57 shares of Veracyte worth $3.35K as of Q2 2026.
  • Veracyte was a new Continuum Advisory position in Q2 2026.
  • Veracyte made up ﹤0.01% of Continuum Advisory's portfolio in Q2 2026, its #1590 holding.
  • Continuum Advisory first reported a position in Veracyte in Q1 2024 and has held it in 6 quarters since.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Continuum Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.